EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Annual Report to the Nation on the Status of Cancer, featuring state‐level statistics after the onset of the COVID‐19 pandemic

Recinda L Sherman iD, Albert U Firth iD, S Jane Henley iD, Rebecca L Siegel iD, Serban Negoita iD, Hyuna Sung iD, Betsy A Kohler iD, Robert N Anderson iD, James Cucinelli iD, Susan Scott iD, Vicki B Benard iD, Lisa C Richardson iD und 2 weitere

Cancer · 2025-05 · 131 (9)

DOI: 10.1002/cncr.35833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 21.04.2025. Verfasst von Recinda L Sherman und 13 weiteren Autor:innen. Beteiligte Einrichtung: North American Association of Central Cancer Registries, Inc., Springfield, Illinois, USA. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This report represents a collaborative effort by the major cancer surveillance organizations to present the definitive US statistics for cancer incidence and mortality.

Methods

Cancer incidence data were obtained from population‐based cancer registries funded by the Centers for Disease Control and Prevention and the National Cancer Institute and compiled by the North American Association of Central Cancer Registries. Cancer death data were obtained from the National Center for Health Statistics' National Vital Statistics System. Statistics are reported by cancer type, sex, race and ethnicity, and age. The potential impact of the coronavirus disease 2019 (COVID‐19) pandemic on incidence was assessed by using state‐level changes compared with previous years, the stringency of COVID‐19 policy restrictions, the magnitude of COVID‐19 death rates, and changes in the use of mammography.

Results

Overall cancer incidence rates per 100,000 were 500 among males and 437 among females. Excluding 2020, cancer incidence rates remained stable (2013–2021) among males and increased 0.3% per year on average (2003–2021) among females. The overall cancer death rate per 100,000 was 173 among males and 126 among females. Cancer death rates decreased by 1.5% per year (2018–2022), slowing from a previous 2.1% decline. Cancer incidence in 2020 declined from prepandemic levels for all demographic groups examined. However, the magnitude of decline was not strongly associated with the study's proxies for health care capacity, health care access, or COVID‐19 policies.

Conclusions

Overall cancer mortality declined over 20 years, even during the COVID‐19 pandemic. Disruptions in health care use early in the pandemic resulted in incidence declines in 2020, but 2021 incidence returned to prepandemic levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeoplasmsHumansFemaleMaleIncidenceUnited StatesRegistriesSARS-CoV-2AgedMiddle AgedAdultPandemicsYoung Adult

Stichwörter der Autor:innen

National Program of Cancer RegistriesNational Vital Statistics SystemNorth American Association of Central Cancer Registries (NAACCR)Surveillance, Epidemiology, and End Results (SEER) Programannual report to the nationcancercoronavirus disease 2019 (COVID‐19)epidemiology

Autor:innen und Institutionen

  • North American Association of Central Cancer Registries, Inc., Springfield, Illinois, USA.
  • Information Management Services, Inc., Rockville, Maryland, USA.
  • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
  • National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA.

ORCID-Profile: Recinda L Sherman, Albert U Firth, S Jane Henley, Rebecca L Siegel, Serban Negoita, Hyuna Sung, Betsy A Kohler, Robert N Anderson, James Cucinelli, Susan Scott, Vicki B Benard, Lisa C Richardson, Ahmedin Jemal, Kathleen A Cronin

Zitieren

APA

Sherman, R. L., Firth, A. U., Henley, S. J., Siegel, R. L., Negoita, S., Sung, H., Kohler, B. A., Anderson, R. N., Cucinelli, J., Scott, S., Benard, V. B., Richardson, L. C., Jemal, A., & Cronin, K. A. (2025). Annual Report to the Nation on the Status of Cancer, featuring state‐level statistics after the onset of the COVID‐19 pandemic. Cancer, 131(9). https://doi.org/10.1002/cncr.35833

Vancouver

Sherman RL, Firth AU, Henley SJ, Siegel RL, Negoita S, Sung H, et al. Annual Report to the Nation on the Status of Cancer, featuring state‐level statistics after the onset of the COVID‐19 pandemic. Cancer. 2025;131(9). doi:10.1002/cncr.35833

BibTeX
@article{Sherman2025,
  author = {Sherman, Recinda L and Firth, Albert U and Henley, S Jane and Siegel, Rebecca L and Negoita, Serban and Sung, Hyuna and Kohler, Betsy A and Anderson, Robert N and Cucinelli, James and Scott, Susan and Benard, Vicki B and Richardson, Lisa C and Jemal, Ahmedin and Cronin, Kathleen A},
  title = {Annual Report to the Nation on the Status of Cancer, featuring state‐level statistics after the onset of the COVID‐19 pandemic},
  journal = {Cancer},
  year = {2025},
  volume = {131},
  number = {9},
  doi = {10.1002/cncr.35833}
}
Kostenlos starten →